Language of Resource
Full Text Available
Open Access / OK to Reproduce
This study evaluated the combined impacts of the COVID-19 pandemic and counteracting OUD policies on enrollment in medications for OUD (MOUD).
Despite immediate improvements in MOUD enrollment in the post-COVID-19 period, this beneficial trend reversed over time. Risk Mitigation Guidelines opioids appeared to have provided additional benefits to sustain retention in OUD care.
Interrupted time series analysis of data from three cohorts of people with presumed OUD in Vancouver (n=760).